Dragan Tešić
Research Subjects
Dragan Tešić has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anastazija Stojšić-Milosavljević
The Institute for Cardiovascular Diseases of Vojvodina
1 shared publication - Dragica Andrić
Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia
1 shared publication - Jadranka Dejanović
Institute for Cardiovascular Diseases of Vojvodina Cardiology Clinic Sremska Kamenica Serbia
1 shared publication Milan Nedeljković
Clinical Center of Serbia Cardiology Clinic Belgrade Serbia
1 shared publication- Milenko Čanković
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
1 shared publication - Milovan Petrovic
Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia
1 shared publication
Latest Publications
- 1 January 2020
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Srce i krvni sudovi
- Vol. 39 (3) , 27-30
Treatment challenges in a very high-risk diabetic patient with coronary artery disease
We present 58-year woman with T2 diabetes mellitus and multiple cardiovascular risk factors who was addmited to our clinic due to unstabile angina. Coronary angiography revealed bifurcation lesion of medial left anterior descending coronary artery (LAD) with 90% stenosis and first diagonal branch (D1) with a vessel diameter of 2 mm, and percutaneous coronary intervention (PCI) with implantation of one drug eluting stent (DES) in medial LAD was performed. During the follow-up optimal blood pressure control was achieved with combination of antihypertensive drugs and poor glycaemic control was managed with adding empagliflosin to metformin. Trimetazidine was initiated as a second-line treatment to reduce angina symptoms. Repeated coronary angiography due to angina one year later showed patent stent in mid LAD, but gracile periphery of LAD and D1 branch, not suitable for PCI. Optimal medical tretment was indicated. Lifestyle changes were also recommended. Ezetimibe was added to statin therapy due to high levels of LDL cholesterol. Further multifactorial aproach and tighter control of risk factors is needed in order to prevent other vascular complications in this patient.
- 1 January 2020
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Srce i krvni sudovi
- Vol. 39 (3) , 27-30
Treatment challenges in a very high-risk diabetic patient with coronary artery disease
We present 58-year woman with T2 diabetes mellitus and multiple cardiovascular risk factors who was addmited to our clinic due to unstabile angina. Coronary angiography revealed bifurcation lesion of medial left anterior descending coronary artery (LAD) with 90% stenosis and first diagonal branch (D1) with a vessel diameter of 2 mm, and percutaneous coronary intervention (PCI) with implantation of one drug eluting stent (DES) in medial LAD was performed. During the follow-up optimal blood pressure control was achieved with combination of antihypertensive drugs and poor glycaemic control was managed with adding empagliflosin to metformin. Trimetazidine was initiated as a second-line treatment to reduce angina symptoms. Repeated coronary angiography due to angina one year later showed patent stent in mid LAD, but gracile periphery of LAD and D1 branch, not suitable for PCI. Optimal medical tretment was indicated. Lifestyle changes were also recommended. Ezetimibe was added to statin therapy due to high levels of LDL cholesterol. Further multifactorial aproach and tighter control of risk factors is needed in order to prevent other vascular complications in this patient.